EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Changing Epidemiology of Candida spp. Causing Bloodstream Infections in a Tertiary Hospital in Northern Greece: Appearance of Candida auris

Athina Pyrpasopoulou iD, Charalampos Zarras iD, Eleni Mouloudi, Georgios Vakalis, Argyro Ftergioti iD, Dimitrios Kouroupis, Anastasia-Izampella Papathanasiou, Elias Iosifidis iD, Stella Goumperi, Charis Lampada, Maria Terzaki iD, Emmanuel Roilides

Pathogens · 2025-02-07 · 14 (2) · 161

DOI: 10.3390/pathogens14020161 ↗

At a glance

Journal article in Pathogens, published online on 2025-02-07. Written by Athina Pyrpasopoulou and 11 co-authors. Institution: 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece. Major MEDLINE topics: Candidemia, Candida, Candida auris, Candidiasis. Cited 23 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

The epidemiology of candidemia has shifted in the past few decades; drug-resistant non-albicans Candida species have become more prevalent worldwide. The aim of this retrospective study was to determine the epidemiology of Candida species isolated from hospitalized neonates, children and adults, and to investigate a potential changing susceptibility pattern in a large general tertiary hospital.

Methods

All unique Candida strains isolated from candidemia cases between 1 January 2020 and 15 October 2024 were identified, and their susceptibility profile was characterized. The distribution pattern in different ward types (medical, surgical, pediatric and ICU) was recorded. Cumulative annual susceptibility profiles were compared.

Results

Candidemia incidence increased during the COVID-19 pandemic, from 0.63/1000 patient-days in 2020 to 0.96/1000 patient-days in 2022, and has since slightly decreased (0.83 and 0.89 in 2023 and 2024, respectively). Candidemia-associated mortality was high (>50%) in 2020 and peaked during the pandemic. During the study period, Candida parapsilosis remained the most frequent Candida spp. However, since the first isolation of Candida auris from the bloodstream in late 2022, and despite intense infection control measures taken, its frequency sharply climbed to the second position after only C. parapsilosis in the first 10 months of 2024 (33.6% vs. 25.2% for C. parapsilosis and 21.0% for C. albicans). While C. albicans has remained highly susceptible to fluconazole (1% resistance rate), C. parapsilosis manifested significant resistance to fluconazole during 2022–2024 (52%). C. auris was universally resistant to azoles and one isolate also resistant to echinocandins.

Conclusions

A high prevalence of azole resistance of C. parapsilosis, the most frequently isolated Candida species, persists, and a significant rise of C. auris was recorded in nosocomial bloodstream infections with severe implications on public health.

Subjects

MeSH terms (MEDLINE)

CandidemiaCandidaCandida aurisCandidiasisHumansGreeceTertiary Care CentersRetrospective StudiesAntifungal AgentsChildAdultMicrobial Sensitivity TestsDrug Resistance, FungalCOVID-19Infant, NewbornChild, PreschoolIncidenceInfantMaleFemaleMiddle AgedAgedAdolescentCross Infection

Author keywords

C. auriscandidemiaepidemiologyresistance

Substances

Antifungal Agents

Authors and institutions

  • 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.
  • Infectious Diseases Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.
  • Laboratory of Microbiology, Hippokration General Hospital, 54642 Thessaloniki, Greece.
  • Intensive Care Unit, Hippokration General Hospital, 54642 Thessaloniki, Greece.
  • 3rd Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.

ORCID profiles: Athina Pyrpasopoulou, Charalampos Zarras, Argyro Ftergioti, Elias Iosifidis, Maria Terzaki

Cite

APA

Pyrpasopoulou, A., Zarras, C., Mouloudi, E., Vakalis, G., Ftergioti, A., Kouroupis, D., Papathanasiou, A. I., Iosifidis, E., Goumperi, S., Lampada, C., Terzaki, M., & Roilides, E. (2025). Changing Epidemiology of Candida spp. Causing Bloodstream Infections in a Tertiary Hospital in Northern Greece: Appearance of Candida auris. Pathogens, 14(2), 161. https://doi.org/10.3390/pathogens14020161

Vancouver

Pyrpasopoulou A, Zarras C, Mouloudi E, Vakalis G, Ftergioti A, Kouroupis D, et al. Changing Epidemiology of Candida spp. Causing Bloodstream Infections in a Tertiary Hospital in Northern Greece: Appearance of Candida auris. Pathogens. 2025;14(2):161. doi:10.3390/pathogens14020161

BibTeX
@article{Pyrpasopoulou2025,
  author = {Pyrpasopoulou, Athina and Zarras, Charalampos and Mouloudi, Eleni and Vakalis, Georgios and Ftergioti, Argyro and Kouroupis, Dimitrios and Papathanasiou, Anastasia-Izampella and Iosifidis, Elias and Goumperi, Stella and Lampada, Charis and Terzaki, Maria and Roilides, Emmanuel},
  title = {Changing Epidemiology of Candida spp. Causing Bloodstream Infections in a Tertiary Hospital in Northern Greece: Appearance of Candida auris},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {161},
  doi = {10.3390/pathogens14020161}
}
Start for free →